Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials

<div>Forest plot of meta-analysis with the ankle-brachial index (ABI) in cell therapy and standard care for critical limb ischemia. (a) Subgroup analyses of bone marrow stem cells (BMSCs) versus peripheral blood stem cells (PBSCs). (b) Subgroup analyses among bone marrow mononuclear cells (BMMNCs) and bone marrow mesenchymal stem cells (BMMSCs). Squares indicate the weighted mean difference, and horizontal lines represent 95% confidence intervals.</div>

Stem Cells International

fig5

Figure 5

Figure 5: Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials 